Heated chemo and immunotherapy for advanced ovarian cancer
Part of Cancer, Immune system & allergy, Women’s health & pregnancy clinical trials.
This trial tests a combination of heated chemotherapy given directly into the abdomen followed by an immunotherapy drug to see if it helps people with advanced ovarian cancer. The goal is to make the immune system better at fighting the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced ovarian cancer (stage IIIC or IVA) of a specific type called high-grade serous.
- You are between 18 and 70 years old.
- Your doctors expect you to live at least 12 months.
- You have a CT scan and a laparoscopic exam showing your cancer is widespread enough.
- Your liver, kidneys, and blood counts are within certain healthy ranges.
- You are able to carry out daily activities with little or no help.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving heated chemotherapy directly into the belly during surgery for stomach cancer. It might help people with cancer that has spread to the lining of the belly but not to other organs.
This early-phase trial tests a lab-made immune cell treatment designed to recognize ovarian cancer and attack it. It may help people with high-risk ovarian cancer who still need effective options.
This trial looks at whether a heated chemotherapy treatment given in the abdomen during a planned second surgery (HIPEC) can improve outcomes for certain advanced ovarian cancers. It is for people who have already had initial chemotherapy and partially responded, with enough health to safely undergo surgery.
This trial studies whether adding a special heated chemotherapy treatment during surgery (called HIPEC) improves outcomes for some people with ovarian, fallopian tube, or primary peritoneal cancer. It compares surgery alone versus surgery plus HIPEC after you’ve had chemotherapy first.
This trial tests a new immunotherapy drug (PD-1/CTLA-4 bispecific) combined with two chemotherapy drugs (nab-paclitaxel and carboplatin) given before surgery for advanced ovarian cancer. The goal is to shrink the tumor enough so it can be completely removed during surgery.
This trial studies a planned surgery to remove as much cancer as possible, followed by heated chemotherapy placed in the belly (called HIPEC). It’s for people with recurrent mucinous ovarian cancer, aiming to control the cancer and improve outcomes.
Hear when a new HIPEC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.